OptimizeRx CEO, Will Febbo, Discusses the Company's Gains In 2021 | TD Ameritrade Network

 

OptimizeRX - TD Ameritrade Network - The Watch List - 04 01 2021

 

OptimizeRx CEO, Will Febbo, joined Nicole Petallides from The Watchlist on the TD Ameritrade Network to discuss drug prices and the company's gains in recent quarters.